Skip to content

Sugammadex and Time to Extubation in Ophthalmic Surgery

Comparison of Sugammadex and Neostigmine for Time to Extubation in Adult Patients Undergoing Routine Ophthalmic Surgery Under General Anesthesia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06632067
Enrollment
262
Registered
2024-10-08
Start date
2023-08-01
Completion date
2023-08-31
Last updated
2024-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Anesthesia Using Endotracheal Intubation, Ophthalmologic Surgical Procedure, Sugammadex, Neostigmine, Extubation Readiness

Keywords

sugammadex, general anesthesia, ophthalmologic surgical procedures

Brief summary

This study is to invastigate if patients treated with sugammadex compared to neostigmine/atropine would be extubate faster upon emergence of anesthesia.

Detailed description

This is a retrospective case-control study including patients aged 18 years or older who underwent ophthalmic surgeries under general anesthesia with tracheal intubation between 2020 and 2022. Patients who received rocuronium as the sole neuromuscular blocking agent and were maintained with sevoflurane or desflurane and intravenous fentanyl were included. Based on the choice of reversal agent for neuromuscular blockade, patients were divided into two groups: the sugammadex group or the neostigmine group. Patients who underwent emergency surgery or combined surgeries with other specialties were excluded. Patient characteristics, including age, gender, ASA classification, weight, and height, were collected. Anesthesia-related medications were recorded. The time points of anesthesia induction, start and end of surgery, reversal agent administration, and tracheal extubation were documented.

Interventions

DRUGsugammadex

sugammadex used for neuromuscular reversal

Neostigmine and Atropine used for neuromuscular reversal

Sponsors

China Medical University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

aged 18 years or older ophthalmic surgeries under general anesthesia with tracheal intubation between 2020 and 2022 received rocuronium as the sole neuromuscular blocking agent maintained with sevoflurane or desflurane and intravenous fentanyl

Exclusion criteria

emergency surgery combined surgeries with other specialties

Design outcomes

Primary

MeasureTime frameDescription
Time From reversal to extubationTime From reversal to extubationTime From reversal to extubation
Time From the end of surgery to reversalTime From the end of surgery to reversalTime From the end of surgery to reversal

Secondary

MeasureTime frameDescription
Time From induction to the end of surgeryTime From induction to the end of surgeryTime From induction to the end of surgery

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026